Federal IDR outcomes: Neurology in New York
In 2025 Q1–Q4, the provider or facility offer prevailed in 84.9% of 2,504 determined Federal IDR dispute line items for neurology in New York. The median prevailing offer was 27.10x the QPA (25th–75th percentile 7.29x–70.48x; n = 2,276). The median time to a decision was 37 business days (n = 2,504).
Determined line items
2,504
2025 Q1–Q4 · 6 split decisions excluded
Provider win rate
84.9%
n = 2,504 · 2025 Q1–Q4
Median days to decision
37
business days, from dispute initiation · n = 2,504 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 2,504 | 84.9% | 27.10x † | 7.29x–70.48x | 2,276 | 37 |
| 2024 Q1–Q4 | 1,750 | 79.1% | 24.06x † | 2.73x–62.75x | 1,705 | 76 |
| 2023 Q1–Q4 | 407 | 80.3% | 35.45x † | 8.26x–71.44x | 396 | 72 |
| 2023 Q1–2025 Q4 | 4,661 | 82.4% | 26.66x † | 5.08x–68.32x | 4,377 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg | 268 | 85.8% | 116.08x † | 265 | 48.5 |
| 95720 Measurement of brain wave activity with video (VEEG), 12-26 hours with review an | 160 | 98.8% | 9.51x | 99 | 50 |
| 36226 Insertion of tube into brain artery for diagnosis or treatment with review by ra | 134 | 88.1% | 35.97x † | 129 | 30 |
| 95937 Testing of nerve-muscle junction | 131 | 83.2% | 24.43x † | 129 | 48 |
| 95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities | 116 | 81.0% | 17.88x | 116 | 55.5 |
| 36223 Insertion of tube into intracranial artery for diagnosis or treatment with revie | 113 | 86.7% | 39.08x † | 112 | 30 |
| 95941 Continuous remote monitoring of nervous system during operation, each hour | 112 | 79.5% | 26.66x † | 109 | 57 |
| 36222 Insertion of tube into extracranial artery for diagnosis or treatment with revie | 102 | 88.2% | 45.02x † | 82 | 29.5 |
| 95939 Placement of skin electrodes and measurement of central motor stimulation in arm | 102 | 80.4% | 48.50x † | 101 | 57 |
| 36225 Insertion of tube into chest artery for diagnosis or treatment with review by ra | 97 | 87.6% | 57.77x † | 78 | 29 |
| 95940 Continuous monitoring of nervous system during operation, each 15 minutes | 90 | 78.9% | 17.92x | 72 | 58 |
| 95822 Measurement of brain wave activity (EEG), in coma or asleep | 87 | 88.5% | 40.70x † | 86 | 41 |
| 99233 Subsequent hospital care with moderate levelof medical decision making, if using | 70 | 92.9% | 8.27x | 61 | 32 |
| 95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li | 43 | 86.0% | 75.69x † | 42 | 42 |
| 99285 Emergency department visit with high level of medical decision making | 36 | 61.1% | 22.77x † | 36 | 18 |
| 36224 Insertion of tube into internal neck artery for diagnosis or treatment with revi | 35 | 85.7% | – | 29 | 36 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in New York · Neurology in all states
FAQ
What is the Federal IDR provider win rate for neurology in New York?
In 2025 Q1–Q4, the provider or facility offer was selected in 84.9% of 2,504 determined dispute line items for neurology in New York. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for neurology in New York?
In 2025 Q1–Q4, the median prevailing offer was 27.10x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 7.29x to 70.48x (n = 2,276 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for neurology in New York?
In 2025 Q1–Q4, the median was 37 business days (n = 2,504 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).